RxDoctor Payments Data

Kaylin Redinger, PA

Physician Assistant · Richlands, NCNPI 1205245511

Payments from drug & device makers

$1,684in general payments, 2019–2025

Across 98 payments — averaging $17.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$332
  • GSK$271
  • Novo Nordisk$161
  • Exact Sciences$102
  • Merck$93
  • Pfizer$83
  • plus $642 from 15 others

What the payments were for

  • Food & beverage$1,684100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,684 in reported general payments places this provider in the 75th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina

Medicare billing

Part B allowed, 2024
$95,243
Medicare patients
181
Services billed
2,223

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter94$95,052
OzempicSemaglutide39$52,008
JardianceEmpagliflozin29$29,523
JanuviaSitagliptin Phosphate27$15,076
EliquisApixaban12$14,368
Janumet XrSitagliptin Phos/Metformin Hcl17$14,361
XareltoRivaroxaban17$12,472
MounjaroTirzepatide11$10,657
Bydureon BciseExenatide Microspheres13$9,859
Breo ElliptaFluticasone/Vilanterol15$9,671
VascepaIcosapent Ethyl12$3,888
Varenicline Tartrate16$3,353
Albuterol Sulfate HfaAlbuterol Sulfate78$2,751
Gabapentin106$2,005
Lantus SolostarInsulin Glargine,hum.Rec.Anlog15$1,947

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Breo Ellipta$271$104,723109 claims
Novo NordiskOzempic$161$52,00839 claims
Boehringer IngelheimJardiance$56$29,52329 claims
MerckJanuvia, Janumet Xr$93$29,43744 claims
PfizerEliquis$83$14,36812 claims
Lilly USA, LLCMounjaro$332$10,65711 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 7,441 physician assistant providers in North Carolina.

Other physician assistant in Richlands

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →